SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sotac Pharmaceutical - Quaterly Results

05 Feb 2024 Evaluate
The sales surged to Rs. 176.81 millions, up 25.78% for the December 2023 quarter as against Rs. 140.57 millions during the corresponding quarter previous year.Net Profit witnessed a 192.75% growth almost the double from Rs. 5.10 millions to Rs. 14.93  millions  of same quarter last year.Operating Profit saw a handsome growth to 32.03 millions from 11.02 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 176.81 140.57 25.78 365.91 291.04 25.72 579.83 731.52 -20.74
Other Income 2.71 0.05 5320.00 5.02 0.73 587.67 2.43 2.08 16.83
PBIDT 32.03 11.02 190.65 56.94 40.97 38.98 84.52 63.63 32.83
Interest 2.29 1.33 72.18 5.71 3.05 87.21 8.61 5.50 56.55
PBDT 27.42 9.69 182.97 48.91 37.92 28.98 75.91 58.13 30.59
Depreciation 6.83 4.32 58.10 11.46 7.68 49.22 16.25 11.26 44.32
PBT 20.59 5.37 283.43 37.45 30.24 23.84 59.66 46.87 27.29
TAX 5.66 0.27 1996.30 10.47 6.57 59.36 14.69 13.91 5.61
Deferred Tax 0.02 -0.37 -105.41 0.27 -1.08 -125.00 -2.15 -0.33 551.52
PAT 14.93 5.10 192.75 26.98 23.67 13.98 44.97 32.96 36.44
Equity 110.50 80.50 37.27 110.50 80.50 37.27 80.50 23.00 250.00
PBIDTM(%) 18.12 7.84 131.08 15.56 14.08 10.54 14.58 8.70 67.58
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×